The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3-(3-chloro-2,5-difluorophenyl)-3-azaspiro[5.5]undecan-9-yl)acetic acid ID: ALA3901994
PubChem CID: 73777175
Max Phase: Preclinical
Molecular Formula: C18H22ClF2NO2
Molecular Weight: 357.83
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)CC1CCC2(CC1)CCN(c1cc(F)cc(Cl)c1F)CC2
Standard InChI: InChI=1S/C18H22ClF2NO2/c19-14-10-13(20)11-15(17(14)21)22-7-5-18(6-8-22)3-1-12(2-4-18)9-16(23)24/h10-12H,1-9H2,(H,23,24)
Standard InChI Key: GVMZIQCXQRZWJK-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
11.4586 -5.5518 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.7424 -5.1419 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
12.8757 -10.4980 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8903 -6.3726 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1737 -7.6090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.1755 -5.1349 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8648 -12.1492 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1531 -11.7316 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8859 -8.8509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8589 -12.9745 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.4485 -10.4882 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8821 -9.6713 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1590 -10.9064 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.6044 -6.7865 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
11.4616 -8.8509 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1737 -6.7838 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5824 -11.7417 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
12.8907 -5.5482 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.8859 -8.0257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.1700 -9.2593 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4616 -8.0257 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4532 -9.6677 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.4618 -6.3750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5988 -5.1400 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
8 7 1 0
11 13 1 0
6 1 1 0
16 4 2 0
3 12 1 0
22 11 1 0
20 9 1 0
20 22 1 0
4 18 1 0
7 17 1 0
15 20 1 0
1 2 1 0
21 5 1 0
19 5 1 0
13 8 1 0
20 12 1 0
5 16 1 0
9 19 1 0
13 3 1 0
7 10 2 0
23 16 1 0
18 6 2 0
4 14 1 0
21 15 1 0
1 23 2 0
18 24 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 357.83Molecular Weight (Monoisotopic): 357.1307AlogP: 4.87#Rotatable Bonds: 3Polar Surface Area: 40.54Molecular Species: ACIDHBA: 2HBD: 1#RO5 Violations: ┄HBA (Lipinski): 3HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 4.63CX Basic pKa: ┄CX LogP: 4.69CX LogD: 1.99Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.78Np Likeness Score: -0.60
References 1. Cox JM, Chu HD, Chelliah MV, Debenham JS, Eagen K, Lan P, Lombardo M, London C, Plotkin MA, Shah U, Sun Z, Vaccaro HM, Venkatraman S, Suzuki T, Wang N, Ashley ER, Crespo A, Madeira M, Leung DH, Alleyne C, Ogawa AM, Souza S, Thomas-Fowlkes B, Di Salvo J, Weinglass A, Kirkland M, Pachanski M, Powles MA, Tozzo E, Akiyama TE, Ujjainwalla F, Tata JR, Sinz CJ.. (2017) Design, Synthesis, and Evaluation of Novel and Selective G-protein Coupled Receptor 120 (GPR120) Spirocyclic Agonists., 8 (1): [PMID:28105274 ] [10.1021/acsmedchemlett.6b00360 ]